13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)
Launched by MERIDIAN BIOSCIENCE, INC. · Jan 20, 2009
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
Adult subjects with suspected H pylori infection will be recruited and will undergo a 13C -Urea breath test (including citrica) with the BreathID test device. Those were found positive will undergo selected PPI treatment for 14 days and after 24 or 72 hours from the completion of the two weeks, will undergo a second breath test. Those found to be negative (false negative), will undergo additional breath tests.
* Those subjects that underwent any antibiotic, bismuth or PPI therapy 4 weeks prior to the trial, are to be excluded.
* Furthermore, pregnant or nursing women and subjects with an a...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults with H.pylori infection.
- Exclusion Criteria:
- • Pregnancy,
- • Nursing,
- • Antibiotic, bismuth or PPI treatment 2 weeks prior to trial,
- • Known sensitivity to Urea or citrica.
About Meridian Bioscience, Inc.
Meridian Bioscience, Inc. is a leading global biotechnology company focused on the development and commercialization of innovative diagnostic products and solutions for infectious diseases, gastrointestinal disorders, and other critical health conditions. With a commitment to advancing patient care, Meridian Bioscience leverages cutting-edge technologies and extensive expertise in molecular diagnostics, immunoassays, and life science research. The company's mission is to enhance diagnostic accuracy and efficiency, ultimately improving clinical outcomes and public health. Through rigorous clinical trials and partnerships, Meridian Bioscience aims to deliver reliable and timely diagnostic tools that empower healthcare professionals and patients alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Petah Tikva, , Israel
Petah Tikva, , Israel
Patients applied
Trial Officials
Haim Shirin, MD
Principal Investigator
Sharon Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials